SN.L
SN.L
GB0009223206
SMITH & NEPHEW PLC ORD USD0.20
Loading chart...

Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Related stocks

SNN
SNN • United Kingdom
Smith & Nephew SNATS, Inc.
27.24 USD
11.4B USD 1Y -25%
DEMANT.CO
DEMANT.CO • Denmark
Demant A/S
341.2 DKK
10.78B USD 1Y +38.3%
LIVN
LIVN • United Kingdom
LivaNova PLC
76.39 USD
4.21B USD 1Y +42.2%
GETI-B.ST
GETI-B.ST • Sweden
Getinge AB ser. B
253.2 SEK
6.9B USD 1Y +18%
SECT-B.ST
SECT-B.ST • Sweden
SECTRA AB ser B
310.2 SEK
5.98B USD 1Y -1.9%
PHIA.AS
PHIA.AS • Netherlands
KON.PHILIPS N.V.
21.78 EUR
23.86B USD 1Y -11.6%
PHG
PHG • Netherlands
Koninklijke Philips N.V. NY Reg
24.24 USD
23.69B USD 1Y -14%
SOON.SW
SOON.SW • Switzerland
SONOVA N
264.6 CHF
18.94B USD 1Y +14.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
25.6% p.a.
Max Drawdown (5Y)
-34.5%
Sharpe Ratio (5Y)
-0.27
Beta Factor
0.67
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Historical Stress Test: Maximum peak-to-trough drawdown of -55.0% in the extended horizon.
ende